ThyCa News

Levoxyl Recall Announced

04/2013

Pfizer’s wholly owned subsidiary, King Pharmaceuticals LLC, has initiated a voluntary recall of the thyroid hormone Levoxyl.

The company also announced that Levoxyl may not become available until 2014.

In addition, the company's letter stated:

“There is no need for patients to return or discard the medication they have, as they may continue to take the medication in accordance with their health care provider’s prescribed directions.”


News Archive